Contineum Therapeutics (CTNM) Other Non-Current Assets (2023 - 2026)
Contineum Therapeutics' (CTNM) quarterly Other Non-Current Assets came in at $312000.0 in Q1 2026, up 7700.0% year-on-year from $4000.0 in Q1 2025, and up 21.88% quarter-over-quarter from $256000.0 in Q4 2025.
Contineum Therapeutics (CTNM) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $312000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 7700.0% year-over-year to $312000.0 in Q1 2026; TTM through Mar 2026 was $312000.0, a 7700.0% increase from a year earlier, with the FY2025 full-year figure at $256000.0, up 8433.33% from the prior year.
- Other Non-Current Assets advanced to $312000.0 in Q1 2026 per CTNM's latest filing, from $256000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.6 million in Q1 2024 and bottomed at $3000.0 in Q2 2024.
- The 4-year median for Other Non-Current Assets is $221000.0 (2025), against an average of $493900.0.
- Biggest YoY gain for Other Non-Current Assets was 8766.67% in 2025; the steepest drop was 99.85% in 2025.
- Year by year, Other Non-Current Assets stood at $1.3 million in 2023, then tumbled by 99.77% to $3000.0 in 2024, then jumped by 8433.33% to $256000.0 in 2025, then grew by 21.88% to $312000.0 in 2026.
- Per Business Quant, the three latest CTNM Other Non-Current Assets figures stand at $312000.0 (Q1 2026), $256000.0 (Q4 2025), and $266000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Contineum Therapeutics | 536.56 Mn | 536.56 Mn | - | 312,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 312,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 266,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 2.62 Mn |
| Dec 31, 2023 | 1.28 Mn |